StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

IDEXX Laboratories pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

IDEXX Laboratories's pe ratio was 49.4× on Nov 11, 2026, against 59.7× a year earlier. Over the last 5 years it ranged from 36.7× to 75.4×, with a median of 49.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202649.4×−4.2
2025Dec 31, 202553.6×+13.8
2024Dec 31, 202439.9×−16.8
2023Dec 29, 202356.6×+4.8
2022Dec 30, 202251.8×−23.6
2021Dec 31, 202175.4×−11.7
2020Dec 31, 202087.1×+32.9
2019Dec 31, 201954.2×+4.2
2018Dec 31, 201850.0×−0.6
2017Dec 29, 201750.6×+0.7
2016Dec 30, 201649.9×+10.3
2015Dec 31, 201539.6×+1.2
2014Dec 31, 201438.4×+7.5
2013Dec 31, 201330.9×+0.6
2012Dec 31, 201230.3×+2.1
2011Dec 30, 201128.2×−2.2
2010Dec 31, 201030.4×+1.8
2009Dec 31, 200928.6×–

More IDEXX Laboratories figures

See a number that looks wrong?